Back to CGEM

Kynam Capital Management, LP → CGEM

Kynam Capital Management, LP CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$47.8M
Q3 2026
Peak value
$56.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$32.2M
Q1 2026$44.3M
Q2 2026$56.7M
Q3 2026$47.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$47.8M3.11M——
Q2 2026$56.7M3.11M——
Q1 2026$44.3M3.11M——
Q4 2025$32.2M3.11M——

Other funds holding CGEM

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M